FR2321890A1 - Nouveaux derives de la quinazoline, leurs sels, leur preparation et les medicaments qui en renferment - Google Patents

Nouveaux derives de la quinazoline, leurs sels, leur preparation et les medicaments qui en renferment

Info

Publication number
FR2321890A1
FR2321890A1 FR7526228A FR7526228A FR2321890A1 FR 2321890 A1 FR2321890 A1 FR 2321890A1 FR 7526228 A FR7526228 A FR 7526228A FR 7526228 A FR7526228 A FR 7526228A FR 2321890 A1 FR2321890 A1 FR 2321890A1
Authority
FR
France
Prior art keywords
substd
piperidine
amino
piperazine
substit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7526228A
Other languages
English (en)
French (fr)
Other versions
FR2321890B1 (cg-RX-API-DMAC10.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to FR7526228A priority Critical patent/FR2321890A1/fr
Publication of FR2321890A1 publication Critical patent/FR2321890A1/fr
Application granted granted Critical
Publication of FR2321890B1 publication Critical patent/FR2321890B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7526228A 1975-08-26 1975-08-26 Nouveaux derives de la quinazoline, leurs sels, leur preparation et les medicaments qui en renferment Granted FR2321890A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7526228A FR2321890A1 (fr) 1975-08-26 1975-08-26 Nouveaux derives de la quinazoline, leurs sels, leur preparation et les medicaments qui en renferment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7526228A FR2321890A1 (fr) 1975-08-26 1975-08-26 Nouveaux derives de la quinazoline, leurs sels, leur preparation et les medicaments qui en renferment

Publications (2)

Publication Number Publication Date
FR2321890A1 true FR2321890A1 (fr) 1977-03-25
FR2321890B1 FR2321890B1 (cg-RX-API-DMAC10.html) 1979-09-14

Family

ID=9159340

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7526228A Granted FR2321890A1 (fr) 1975-08-26 1975-08-26 Nouveaux derives de la quinazoline, leurs sels, leur preparation et les medicaments qui en renferment

Country Status (1)

Country Link
FR (1) FR2321890A1 (cg-RX-API-DMAC10.html)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2919800A1 (de) * 1978-05-18 1979-11-22 Pfizer 4-amino-2-piperidinochinazolin-derivate, verfahren zu ihrer herstellung und solche derivate enthaltende arzneimittel
EP0009465A1 (de) * 1978-09-20 1980-04-02 Ciba-Geigy Ag N-(1-(4-Amino-2-chinazolinyl)-3- oder -4-piperidyl-lactame, Verfahren zu ihrer Herstellung, sowie pharmazeutische Präparate enthaltend diese Verbindungen
EP0034471A1 (en) * 1980-02-19 1981-08-26 Orion-Yhtymä Oy Piperidinoquinazolines and a process for the preparation thereof
US4309541A (en) * 1978-09-20 1982-01-05 Ciba-Geigy Corporation Piperidinyl-lactams
WO1997020820A1 (en) * 1995-12-01 1997-06-12 Novartis Ag Heteroaryl compounds
US5675006A (en) * 1992-08-31 1997-10-07 Brantford Chemicals Inc. Methods of making ureas and guanidines, including, terazosin, prazosin, doxazosin, tiodazosin, trimazosin, quinazosin, and bunazosin (exemplary of 2- substituted quinazoline compounds), and meobentine, and bethanidine and intermediates therefor
WO2002048124A3 (en) * 2000-12-15 2003-06-05 Hoffmann La Roche Piperazine derivatives
WO2005000305A1 (en) * 2003-06-20 2005-01-06 Eli Lilly And Company 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake
WO2009107571A1 (ja) * 2008-02-27 2009-09-03 住友化学株式会社 アルキルピペリジン－３－イルカーバメートの光学分割方法およびその中間体
WO2009119700A1 (ja) * 2008-03-26 2009-10-01 住友化学株式会社 ピペリジン－３－イルカーバメート化合物の製造方法およびその光学分割方法
JP2009256337A (ja) * 2008-03-26 2009-11-05 Sumitomo Chemical Co Ltd ピペリジン−３−イルカーバメート化合物の製造方法
CN107814792A (zh) * 2016-09-14 2018-03-20 中国科学院上海药物研究所 一类喹唑啉衍生物、其组合物及用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2919800A1 (de) * 1978-05-18 1979-11-22 Pfizer 4-amino-2-piperidinochinazolin-derivate, verfahren zu ihrer herstellung und solche derivate enthaltende arzneimittel
EP0009465A1 (de) * 1978-09-20 1980-04-02 Ciba-Geigy Ag N-(1-(4-Amino-2-chinazolinyl)-3- oder -4-piperidyl-lactame, Verfahren zu ihrer Herstellung, sowie pharmazeutische Präparate enthaltend diese Verbindungen
US4309541A (en) * 1978-09-20 1982-01-05 Ciba-Geigy Corporation Piperidinyl-lactams
EP0034471A1 (en) * 1980-02-19 1981-08-26 Orion-Yhtymä Oy Piperidinoquinazolines and a process for the preparation thereof
US5675006A (en) * 1992-08-31 1997-10-07 Brantford Chemicals Inc. Methods of making ureas and guanidines, including, terazosin, prazosin, doxazosin, tiodazosin, trimazosin, quinazosin, and bunazosin (exemplary of 2- substituted quinazoline compounds), and meobentine, and bethanidine and intermediates therefor
US5686612A (en) * 1992-08-31 1997-11-11 Brantford Chemicals Inc. Methods of making ureas and guanidines, including terazosin, prazosin, doxazosin, tiodazosin, trimazosin, quinazosin, and bunazosin (exemplary of 2-substituted quinazoline compounds), and meobentine, and bethanidine and intermediates thereof
US6080860A (en) * 1992-08-31 2000-06-27 Brantford Chemicalss Inc. Methods of making ureas and guanidines including, terazosin, prazosin, doxazosin, tiodazosin, trimazosin, quinazosin and bunazosin (exemplary of 2-substituted quinazoline compounds), and meobentine, and bethanidine and intermediates therefor
WO1997020820A1 (en) * 1995-12-01 1997-06-12 Novartis Ag Heteroaryl compounds
WO2002048124A3 (en) * 2000-12-15 2003-06-05 Hoffmann La Roche Piperazine derivatives
US7022707B2 (en) 2000-12-15 2006-04-04 Hoffman-La Roche Inc. Piperazine derivatives
WO2005000305A1 (en) * 2003-06-20 2005-01-06 Eli Lilly And Company 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake
US7432280B2 (en) 2003-06-20 2008-10-07 Eli Lilly And Company 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake
WO2009107571A1 (ja) * 2008-02-27 2009-09-03 住友化学株式会社 アルキルピペリジン－３－イルカーバメートの光学分割方法およびその中間体
JP2009227665A (ja) * 2008-02-27 2009-10-08 Sumitomo Chemical Co Ltd アルキルピペリジン−３−イルカーバメートの光学分割方法およびその中間体
WO2009119700A1 (ja) * 2008-03-26 2009-10-01 住友化学株式会社 ピペリジン－３－イルカーバメート化合物の製造方法およびその光学分割方法
JP2009256298A (ja) * 2008-03-26 2009-11-05 Sumitomo Chemical Co Ltd ピペリジン−３−イルカーバメート化合物の光学分割方法およびその中間体
JP2009256337A (ja) * 2008-03-26 2009-11-05 Sumitomo Chemical Co Ltd ピペリジン−３−イルカーバメート化合物の製造方法
CN107814792A (zh) * 2016-09-14 2018-03-20 中国科学院上海药物研究所 一类喹唑啉衍生物、其组合物及用途
CN107814792B (zh) * 2016-09-14 2021-08-10 中国科学院上海药物研究所 一类喹唑啉衍生物、其组合物及用途

Also Published As

Publication number Publication date
FR2321890B1 (cg-RX-API-DMAC10.html) 1979-09-14

Similar Documents

Publication Publication Date Title
FR2321890A1 (fr) Nouveaux derives de la quinazoline, leurs sels, leur preparation et les medicaments qui en renferment
CO4410321A1 (es) Compuestos ciclicos condensados con funciones aminoacidas sustituidas y derivados ester de los mismos
EE03139B1 (et) Piperasiiniderivaadid, nende kasutamine ja farmatseutiline kompositsioon
FR2449089A1 (fr) B-lactames derives de l'acide penicillanique, leur preparation et leurs utilisations therapeutiques
ES2322602T3 (es) Compuestos heterotetraciclicos condensados y su uso como inhibidor de polimerasa del vhc.
ES8105299A1 (es) Procedimiento para preparar aroilimidazol-2-onas
NO175259C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive triazolo-1,4-diazepinforbindelser
DK0625977T3 (da) Piperazinderivater som 5-1A-antagonister
GB9408185D0 (en) New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
ATE132868T1 (de) Azabicyclo- und azacyclooxime und -amine mit cholinergischer wirkung und ihre pharmazeutisch annehmbaren salze
DK26289A (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
DE69311118D1 (de) Phosphono-arylethanolamin-verbindungen mit antihyperglykämischer und/oder antiobeser wirkung
ES2016060A6 (es) Un metodo para preparar derivados de butinilamina.
ES2012648A6 (es) Procedimiento para la preparacion de nuevos derivados de 1,4-benzoxazina y 1,4-benzotiazina.
DE69329084D1 (de) Benzoxazepin-Derivate als Cholinesterase-Inhibitoren
AU8519601A (en) 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(ene)oic acid as therapeutic agents
ES2054095T3 (es) Procedimiento para la preparacion de nuevos derivados tieniloxi-alquilaminicos.
SE7607856L (sv) Forfarande for framstellning av 2-bensopyranonderivat och deras anvendning som lekemedel
ZA851698B (en) Pharmacologically active piperidine derivatives and their use
ES8101045A1 (es) Procedimiento para la preparacion de derivados de acidos pi-rrolidinilsulfamoilbenzoicos sustituidos
ES2112994T3 (es) Analogos de clomifeno no metabolizables utilizados en el tratamiento de tumores resistentes al tamoxifeno.
HUT53089A (en) Process for producing cyclic guanidine derivatives of calcium-antagonistic activity and pharmaceutical compositions containing them
FI871253A0 (fi) 1-/3-(2-dialkylaminoetoxi)-2 -tienyl/-3-fenyl-1-propanoner och deras syraadditionssalter, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska sammansaettningar.
IT1213219B (it) Derivati amminoalchilnaftalenici ad attivita' farmacologica.
ATE64095T1 (de) Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis.

Legal Events

Date Code Title Description
ST Notification of lapse